Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population‐based propensity‐score adjusted study in the Netherlands
Open Access
- 24 June 2016
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 139 (9) , 2082-2094
Abstract
As the value of palliative primary tumor resection in stage IV colorectal cancer (CRC) is still under debate, the purpose of this population‐based study was to investigate if palliative primary tumor resection as the initial treatment after diagnosis was associated with improved overall survival. All patients with stage IV colorectal adenocarcinoma (2008–2011) were selected from the Netherlands Cancer Registry, and patients undergoing treatment with curative intent (i.e., metastasectomy, radiofrequency ablation and/or hyperthermic intraperitoneal chemotherapy), or best supportive care were excluded. After propensity score matching, a multivariable Cox proportional hazard model was performed to determine the association between treatment strategy and mortality. From a total group of 10,371 patients with stage IV CRC, 2,746 patients (26%) underwent an elective palliative resection of the primary tumor, whether or not followed by systemic therapy, and 3,345 patients (32%) were initially treated with palliative systemic therapy. After propensity score matching, median overall survival in these groups was 17.2 months (95% CI 16.3–18.1) and 11.5 months (95% CI 11.0–12.0), respectively. In Cox regression analysis, primary tumor resection was significantly associated with improved overall survival (hazard ratio of death = 0.44 [95% CI 0.35–0.55], p < 0.001). This large population‐based study shows an overall survival benefit for patients with incurable stage IV CRC who underwent primary tumor resection as the initial treatment after diagnosis, compared to patients who started systemic therapy with the primary tumor in situ. This result is an argument in favor of resection of the primary tumor, even when patients have little to no symptoms.Keywords
This publication has 45 references indexed in Scilit:
- Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastasesClinical & Experimental Metastasis, 2015
- Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population‐based seriesColorectal Disease, 2010
- Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006Annals of Oncology, 2010
- Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic DiseaseThe Oncologist, 2009
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved ChemotherapyJournal of Clinical Oncology, 2009
- Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial TreatmentJournal of Clinical Oncology, 2009
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Chemotherapy Has Also an Effect on Primary Tumor in Colon CarcinomaAnnals of Surgical Oncology, 2008
- Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trialThe Lancet, 2007
- Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastasesBritish Journal of Surgery, 2005